Literature DB >> 14685090

Recent advances in telomere biology: implications for human cancer.

Alan K Meeker1, Angelo M De Marzo.   

Abstract

PURPOSE OF REVIEW: Research into the basic biology of telomeres continues to reveal details relevant to fundamental aspects of human cancer. The goal of this review is to highlight discoveries made within the last year, with emphasis on their relevance to cancer prevention, diagnosis, prognostics, and treatment. RECENT
FINDINGS: Increasing evidence indicates that dysfunctional telomeres likely play a causal role in the process of malignant transformation, in at least a fraction of human cancers, by initiating chromosomal instability. Telomeres form protective capping structures composed of telomeric DNA complexed with a multitude of associated proteins, the loss of which can have profound effects on telomeric stability. Critical telomeric shortening can lead to telomere "uncapping" and may occur at the earliest recognizable stages of malignant transformation in epithelial tissues. The widespread activation of the telomere synthesizing enzyme telomerase in human cancers not only confers unlimited replicative potential but also prevents intolerable levels of chromosomal instability. Several details regarding telomere structure and telomerase regulation have recently been elucidated, providing new targets for therapeutic exploitation. Various therapeutic strategies aimed at either telomerase or its telomeric substrate are showing promise and may synergize with established anti-cancer agents. Further support for anti-telomerase approaches comes from recent studies indicating that telomerase may possess additional functions, beyond telomere maintenance, that support the growth and survival of tumor cells.
SUMMARY: Substantial progress has been made in understanding the complex relationships that exist between telomeres and cancer. However, important issues, such as transient activation of telomerase in normal cells and the potential for tumor cell immortalization via telomerase independent means, remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14685090     DOI: 10.1097/00001622-200401000-00007

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  18 in total

1.  Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.

Authors:  Elisabetta Kuhn; Alan K Meeker; Kala Visvanathan; Amy L Gross; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

Review 2.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

Review 3.  Cancer telomeres and white crows.

Authors:  Alan K Meeker
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 4.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

5.  The longest telomeres: a general signature of adult stem cell compartments.

Authors:  Ignacio Flores; Andres Canela; Elsa Vera; Agueda Tejera; George Cotsarelis; María A Blasco
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

6.  Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.

Authors:  Z Qi; R Mi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

Review 7.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Short telomeres in patients with chronic schizophrenia who show a poor response to treatment.

Authors:  Wu-Yang Yu; Hsueh-Wen Chang; Ching-Hua Lin; Chung-Lung Cho
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

9.  Effects of AZT and RNA-protein complex (FA-2-b-beta) extracted from Liang Jin mushroom on apoptosis of gastric cancer cells.

Authors:  Yan-Qing Sun; Tian-Kang Guo; Ya-Ming Xi; Che Chen; Jin Wang; Zi-Ren Wang
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

10.  The role of peroxisome proliferator-activated receptors in colorectal cancer.

Authors:  Joo-In Park; Jong-Young Kwak
Journal:  PPAR Res       Date:  2012-09-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.